Chapter 7. Management of Depressed High-Density Lipoprotein Cholesterol

  1. Peter P. Toth M.D., PH.D. Director of Preventive Cardiology Chief of Medicine Clinical Associate Professor1,2,3,4,
  2. Kevin C. Maki PH.D. President Chief Science Officer5

Published Online: 1 OCT 2008

DOI: 10.1002/9780470696873.ch7

Book Title

Practical Lipid Management: Concepts and Controversies

Practical Lipid Management: Concepts and Controversies

Additional Information

How to Cite

Toth, P. P. and Maki, K. C. (2008) Management of Depressed High-Density Lipoprotein Cholesterol , in Practical Lipid Management: Concepts and Controversies, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470696873.ch7

Author Information

  1. 1

    Sterling Rock Falls Clinic, Ltd., USA

  2. 2

    CGH Medical Center Sterling, Illinois, USA

  3. 3

    Departments of Family and Community Medicine, University of Illinois College of Medicine Peoria, Illinois, USA

  4. 4

    Southern Illinois University School of Medicine, Springfield, Illinois, USA

  5. 5

    Provident Clinical Research & Consulting, Inc., Glen Ellyn, Illinois and Bloomington, Indiana, USA

Publication History

  1. Published Online: 1 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470056905

Online ISBN: 9780470696873

SEARCH

CHAPTER TOOLS

Get PDF (770K)

Keywords:

  • HDL cholesterol;
  • Cooperative Lipoprotein Phenotyping Study (CLPS);
  • National Cholesterol Education Program (NCEP);
  • HDL antiatherogenic effects;
  • very low-density lipoprotein (VLDL) and LDL;
  • scavenger receptor B-I (SR-BI);
  • HDL and insulin resistance;
  • low HDL pharmacologic management;
  • fibrates and triglyceride metabolism

Summary

This chapter contains sections titled:

  • The Relationship between HDL and Risk For CVD

  • Prevalence of Low HDL-C

  • Goals for HDL Treatment

  • Antiatherogenic Effects of HDL

  • HDL and Insulin Resistance

  • Effects of Lifestyle Modification on Serum HDL

  • Pharmacologic Management of Low HDL

  • Controversy: Do we Need HDL Treatment Goals?

Get PDF (770K)